The company’s success was greater than expected, said Stuart Essig, Integra’s CEO. The company reported a GAAP net income of $16.5 million, an increase from the third quarter of 2009.
Integra’s orthopedic business has earned $72,970 during the third quarter, a 13.8 percent increase over last year. The company’s neurosurgery business also experienced a 3.8 percent increase to $69,816.
Read the release on Integra LifeSciences 3Q FY 2010 financial report.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences Annouces Milestone for Vu a-POD Device
– Integra LifeSciences Contracts With The Broadlane Group
– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
